Source link : https://newshealth.biz/health-news/new-bispecific-t-cell-engager-approved-for-multiple-myeloma/
(MedPage Today) — The FDA on Wednesday granted accelerated approval to linvoseltamab (Lynozyfic) for relapsed or refractory multiple myeloma after at least four prior lines of therapy. A B-cell maturation antigen (BCMA)-directed bispecific antibody… Source link : https://www.medpagetoday.com/hematologyoncology/myeloma/116373 Author : Publish date : 2025-07-02 19:50:00 Copyright for syndicated content belongs to the linked Source.
The post New Bispecific T-Cell Engager Approved for Multiple Myeloma first appeared on News Health.
—-
Author : News Health
Publish date : 2025-07-02 19:50:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8